$491.65 Million in Sales Expected for Genesco Inc. (NYSE:GCO) This Quarter

Share on StockTwits

Brokerages predict that Genesco Inc. (NYSE:GCO) will report $491.65 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Genesco’s earnings, with estimates ranging from $482.30 million to $501.00 million. Genesco posted sales of $653.89 million in the same quarter last year, which suggests a negative year over year growth rate of 24.8%. The business is scheduled to report its next earnings results on Friday, September 6th.

According to Zacks, analysts expect that Genesco will report full-year sales of $2.21 billion for the current fiscal year, with estimates ranging from $2.20 billion to $2.21 billion. For the next fiscal year, analysts expect that the business will report sales of $2.24 billion, with estimates ranging from $2.23 billion to $2.26 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Genesco.

Genesco (NYSE:GCO) last released its earnings results on Friday, May 31st. The company reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.29. The company had revenue of $495.70 million during the quarter, compared to the consensus estimate of $479.36 million. Genesco had a positive return on equity of 8.85% and a negative net margin of 1.70%. Genesco’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.06) EPS.

A number of analysts recently weighed in on GCO shares. Zacks Investment Research upgraded Genesco from a “sell” rating to a “hold” rating in a research report on Tuesday, May 14th. Pivotal Research reaffirmed a “hold” rating and issued a $45.00 price target on shares of Genesco in a research note on Monday, June 3rd. TheStreet cut Genesco from a “b” rating to a “c+” rating in a research note on Wednesday, June 5th. Finally, ValuEngine cut Genesco from a “buy” rating to a “hold” rating in a research note on Friday, March 1st. Five equities research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $42.60.

In other Genesco news, Director Thurgood Marshall, Jr. sold 1,690 shares of the business’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $44.57, for a total value of $75,323.30. Following the sale, the director now directly owns 9,724 shares of the company’s stock, valued at $433,398.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 4.40% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Oppenheimer Asset Management Inc. purchased a new stake in Genesco in the fourth quarter worth about $48,000. PNC Financial Services Group Inc. grew its position in shares of Genesco by 24.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,350 shares of the company’s stock worth $60,000 after purchasing an additional 265 shares in the last quarter. Meeder Asset Management Inc. grew its position in shares of Genesco by 303.8% during the first quarter. Meeder Asset Management Inc. now owns 2,435 shares of the company’s stock worth $112,000 after purchasing an additional 1,832 shares in the last quarter. Investors Research Corp purchased a new stake in shares of Genesco during the first quarter worth about $146,000. Finally, NumerixS Investment Technologies Inc grew its position in shares of Genesco by 500.0% during the first quarter. NumerixS Investment Technologies Inc now owns 3,600 shares of the company’s stock worth $164,000 after purchasing an additional 3,000 shares in the last quarter. 94.82% of the stock is currently owned by institutional investors and hedge funds.

NYSE:GCO traded down $0.13 during mid-day trading on Wednesday, reaching $45.04. The stock had a trading volume of 6,630 shares, compared to its average volume of 352,964. The company has a market capitalization of $739.91 million, a price-to-earnings ratio of 13.75, a PEG ratio of 2.44 and a beta of 0.64. Genesco has a one year low of $37.00 and a one year high of $51.85. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.65 and a quick ratio of 0.64.

Genesco announced that its board has approved a stock buyback program on Friday, May 3rd that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 11.7% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

Genesco Company Profile

Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children.

See Also: Compound Interest and Why It Matters When Investing

Get a free copy of the Zacks research report on Genesco (GCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Amcor plc  Given $10.74 Average Target Price by Brokerages
Amcor plc Given $10.74 Average Target Price by Brokerages
Zacks: EP Energy Corporation  Given $1.21 Consensus Target Price by Analysts
Zacks: EP Energy Corporation Given $1.21 Consensus Target Price by Analysts
Brokerages Expect Stoke Therapeutics  to Post  Earnings Per Share
Brokerages Expect Stoke Therapeutics to Post Earnings Per Share
Zacks: Analysts Expect CNH Industrial NV  to Post $0.29 Earnings Per Share
Zacks: Analysts Expect CNH Industrial NV to Post $0.29 Earnings Per Share
Exelixis, Inc.  Expected to Announce Earnings of $0.25 Per Share
Exelixis, Inc. Expected to Announce Earnings of $0.25 Per Share
Zacks: Analysts Anticipate Triplepoint Venture Growth BDC Corp  to Announce $0.38 Earnings Per Share
Zacks: Analysts Anticipate Triplepoint Venture Growth BDC Corp to Announce $0.38 Earnings Per Share


© 2006-2019 Ticker Report